Investor Roadmap

Full name of the company

Belmedpreparaty, Republican Unitary Production Enterprise

Year of establishment

1929

Primary activity

Manufacturing of pharmaceuticals for medical use

Products, services description (detailed, indicating CN FEA code)

- Eye drops. - Solutions for injection. The nomenclature of medicines for the project will be determined after elaboration of technical solutions, marketing analysis and development of a business plan.

Superior body

The Pharmaceutical Holdings Company "Belpharmprom"

General reference and analytical information about the company

Belmedpreparaty is the oldest pharmaceutical company in Belarus. The enterprise produces about 260 names of medicines (more than 350 dosage forms) belonging to more than 20 pharmacotherapeutic groups. The production facilities of the organization are located on a territory with a total area of more than 18 hectares and include 14 technological and 5 auxiliary workshops. The main activity is the production of pharmaceuticals. Other activities carried out by the enterprise: -production of canteen services at the enterprise; -transportation services; -rent; -scientific developments, etc.

Authorized capital size of the company, thousand $

25.6

Revenue, thousand $

128224

Net profit (net loss), thousand $

11034

Current liquidity ratio

1.85

Working capital financed by equity to total assets ratio

0.46

Number of employees as on the month of filling the form, people

2299

Average salary as on the month of filling the form, BYN

1738,7

Type of investment project

Investment projects offered for implementation

Total volume of investments, thousand $

19833.3

Expected input of an investor, thousand $

19000

Project period

2023-2027

Investor participation form

Contribution to the statutory fund of a new enterprise

Project description

RUE “Belmedpreparaty” is the biggest manufacture of means for treatment ophthalmological diseases in the Republic of Belarus. For the purpose of extending medicine nomenclature, increasing production facilities as well as producing medicines in modern more convenient primary package it is intended to implement the project “Creating production of medicines using blow-fill-seal technology” Creatable facilities will allow to extend nomenclature of produced eye drops and injection medicines for domestic market as well as for foreign markets owing to increasing production volume, development and supplying new called-for medicines to the manufacture. Project implementation will allow to export significant part of production providing

The nomenclature of the product to be produced with indication of the CN FEA code

Medicines in the form of eye drops and injection solutions using blow-feel-seal technology

Annual revenues once fully operational (without VAT, thousand $)

8015.9

Simple pay-back period, yrs

9.1

Dymanic pay-back period, yrs

10.9

NPV, thousand $

0,1223

IRR, %

5.7

Discount Rate, %

5.5

Potential customer

Products manufactured by Belmedpreparaty are designed to meet the needs of medical institutions and the population in highly effective medicines. EAEU countries: 41.1% - 48.5% Market of Belarus: 58.9% - 51.5%

Key benefits of the project

1. The use of advanced technology and technology in production; 2. Provision of the domestic pharmaceutical market with effective medicines, which allow providing the population with sufficient medical care; 3. Faster access to foreign markets with competitive products in order to obtain foreign exchange funds; 4. Improvement of working conditions for personnel due to the introduction of high-tech equipment and modern technologies; 5. Improvement of general economic indicators of development, both by increasing the proceeds from the sale of products, and by reducing production costs, ensuring an increase in labor productivity.

Level of project development

Marketing analysis, determination of the range of products is planned for the III quarter of 2023; Business plan development is planned for the IV quarter 2023